Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Cerilliant
Argus Health
UBS
McKinsey
McKesson
Colorcon
Chinese Patent Office

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,986,904

« Back to Dashboard

Summary for Patent: 6,986,904
Title:Formulation
Abstract:A new metered unit dose comprising 40 .mu.g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.
Inventor(s): Nilsson; Hans (Lund, SE), Santesson; Gordon (Horby, SE)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:10/716,357
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 6,986,904

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,986,904

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9604486Dec 05, 1996

International Patents Family Members for US Patent 6,986,904

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 239482 ➤ Try a Free Trial
Austria 369118 ➤ Try a Free Trial
Australia 5421198 ➤ Try a Free Trial
Australia 726515 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
AstraZeneca
Deloitte
Daiichi Sankyo
McKinsey
UBS
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.